Mineralys Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-1.767; its P/E ratio is -6.08; Mineralys Therapeutics, Inc. is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.67. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -54.27M	$ -22.76M	$ -12.14M	$ 17.27M	$ -10.01M
EBITDA	$ -56.33M	-	$ -14.12M	$ 16.41M	$ -10.01M
Net Income Common Stockholders	$ -54.27M	$ -22.76M	$ -12.14M	$ 17.27M	$ -9.07M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 49.30M	$ 86.30M	$ 101.14M	$ 138.25M	$ 110.11M
Total Assets	$ 251.64M	$ 277.56M	$ 291.22M	$ 306.44M	$ 114.44M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -49.30M	$ -86.30M	$ -101.14M	$ -138.25M	$ -110.11M
Total Liabilities	$ 10.48M	$ 13.54M	$ 6.21M	$ 10.56M	$ 166.71M
Stockholders Equity	$ 241.15M	$ 264.01M	$ 285.01M	$ 295.88M	$ -52.27M
Cash Flow	-
Free Cash Flow	$ -28.98M	-	$ -20.39M	$ -12.77M	$ -10.19M
Operating Cash Flow	$ -28.98M	$ -19.03M	$ -20.39M	$ -12.77M	$ -10.19M
Investing Cash Flow	$ -8.09M	$ 4.01M	$ -16.14M	$ -140.25M	$ 50.00M
Financing Cash Flow	$ 74.00K	$ 184.00K	$ -581.00K	$ 203.57M	$ -1.07M

Currency in USD

Mineralys Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Mineralys Therapeutics, Inc. Debt to Assets

Balance Sheet >

Mineralys Therapeutics, Inc. Cash Flow

Cash Flow >

Mineralys Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing